A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e

Virology. 2025 May:606:110510. doi: 10.1016/j.virol.2025.110510. Epub 2025 Mar 19.

Abstract

It is a high priority to enhance the efficacy of seasonal influenza vaccines based on hemagglutinin (HA) strain-specific neutralizing immunity. Here, we investigated a vaccination strategy of supplementing inactivated split seasonal vaccines with a virus-like particle vaccine containing multi-subtype neuraminidase (NA) and M2 ectodomain (M2e) repeat (NA-M2e) in mice. NA-M2e and split combined vaccine (S + NA-M2e) stimulated a unique pattern of innate immune responses within a day after intramuscular injection of mice. The combined S + NA-M2e vaccination induced enhanced levels of IgG antibodies to viral antigens, hemagglutination inhibiting activities, and humoral and cellular immune responses to NA and M2e. The addition of NA-M2e to split vaccination provided higher efficacy of protection against homologous and heterologous viruses compared to split alone, where NA-M2e significantly contributed to enhancing protection under naïve and primed mouse models. This study supports a vaccination strategy to improve the efficacy of seasonal vaccines by providing additional immunity to NA and M2e.

Keywords: Adaptive immunity; Cross-protection; Innate immune responses; NA-M2e universal vaccine; Seasonal vaccine; Supplemented vaccination.

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Female
  • Immunoglobulin G / blood
  • Influenza Vaccines* / administration & dosage
  • Influenza Vaccines* / genetics
  • Influenza Vaccines* / immunology
  • Mice
  • Mice, Inbred BALB C
  • Neuraminidase* / genetics
  • Neuraminidase* / immunology
  • Orthomyxoviridae Infections* / immunology
  • Orthomyxoviridae Infections* / prevention & control
  • Orthomyxoviridae Infections* / virology
  • Vaccination
  • Vaccine Efficacy
  • Vaccines, Inactivated / administration & dosage
  • Vaccines, Inactivated / immunology
  • Vaccines, Virus-Like Particle / administration & dosage
  • Vaccines, Virus-Like Particle / immunology
  • Viral Matrix Proteins* / genetics
  • Viral Matrix Proteins* / immunology
  • Viral Proteins* / genetics
  • Viral Proteins* / immunology
  • Viroporin Proteins

Substances

  • Neuraminidase
  • Influenza Vaccines
  • Antibodies, Viral
  • Viral Matrix Proteins
  • Vaccines, Inactivated
  • M2 protein, Influenza A virus
  • Immunoglobulin G
  • Vaccines, Virus-Like Particle
  • Viral Proteins
  • NA protein, influenza A virus
  • Viroporin Proteins